These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 7638369)

  • 1. Measures of systemic activity of inhaled glucocorticosteroids in children: a comparison of urine cortisol excretion and knemometry.
    Wolthers OD; Pedersen S
    Respir Med; 1995 May; 89(5):347-9. PubMed ID: 7638369
    [No Abstract]   [Full Text] [Related]  

  • 2. Short-term knemometry and urine cortisol excretion in children treated with fluticasone propionate and budesonide: a dose response study.
    Agertoft L; Pedersen S
    Eur Respir J; 1997 Jul; 10(7):1507-12. PubMed ID: 9230238
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adrenal suppression with inhaled budesonide and fluticasone propionate given by large volume spacer to asthmatic children.
    Clark DJ; Clark RA; Lipworth BJ
    Thorax; 1996 Sep; 51(9):941-3. PubMed ID: 8984708
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A randomized, double-blind dose reduction study to compare the minimal effective dose of budesonide Turbuhaler and fluticasone propionate Diskhaler.
    Agertoft L; Pedersen S
    J Allergy Clin Immunol; 1997 Jun; 99(6 Pt 1):773-80. PubMed ID: 9215245
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Short-term lower-leg growth rate and urine cortisol excretion in children treated with ciclesonide.
    Agertoft L; Pedersen S
    J Allergy Clin Immunol; 2005 May; 115(5):940-5. PubMed ID: 15867849
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adrenal suppression with chronic dosing of fluticasone propionate compared with budesonide in adult asthmatic patients.
    Clark DJ; Lipworth BJ
    Thorax; 1997 Jan; 52(1):55-8. PubMed ID: 9039246
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Knemometric assessment of systemic activity of once daily intranasal dry-powder budesonide in children.
    Wolthers OD; Pedersen S
    Allergy; 1994 Feb; 49(2):96-9. PubMed ID: 8172365
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Budesonide treatment of moderate and severe asthma in children: a dose-response study.
    Pedersen S; Hansen OR
    J Allergy Clin Immunol; 1995 Jan; 95(1 Pt 1):29-33. PubMed ID: 7822661
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An assessment of the systemic activity of single doses of inhaled fluticasone propionate in healthy volunteers.
    Grahnén A; Eckernäs SA; Brundin RM; Ling-Andersson A
    Br J Clin Pharmacol; 1994 Dec; 38(6):521-5. PubMed ID: 7888290
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of the antiasthmatic, oropharyngeal, and systemic glucocorticoid effects of budesonide administered through a pressurized aerosol plus spacer or the Turbuhaler dry powder inhaler.
    Toogood JH; White FA; Baskerville JC; Fraher LJ; Jennings B
    J Allergy Clin Immunol; 1997 Feb; 99(2):186-93. PubMed ID: 9042043
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systemic activity of inhaled topical steroid in toddlers studied by knemometry.
    Bisgaard H
    Acta Paediatr; 1993 Dec; 82(12):1066-71. PubMed ID: 8155929
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Controlled study of linear growth in asthmatic children during treatment with inhaled glucocorticosteroids.
    Wolthers OD; Pedersen S
    Pediatrics; 1992 May; 89(5 Pt 1):839-42. PubMed ID: 1579391
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systemic effects of two nasally administered glucocorticosteroids.
    Wihl JA; Andersson KE; Johansson SA
    Allergy; 1997 Jun; 52(6):620-6. PubMed ID: 9226055
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Comparison of Short-Term Growth During Treatment with Two Dry Powder Combinations of Inhaled Corticosteroids and Long-Acting β₂-Agonists.
    Wolthers OD; Shah T
    J Aerosol Med Pulm Drug Deliv; 2015 Jun; 28(3):182-8. PubMed ID: 25166221
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Normal diurnal variation in serum cortisol concentration in asthmatic children treated with inhaled budesonide.
    Volovitz B; Kauschansky A; Nussinovitch M; Harel L; Varsano I
    J Allergy Clin Immunol; 1995 Dec; 96(6 Pt 1):874-8. PubMed ID: 8543743
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparison of the systemic bioactivity of inhaled budesonide and fluticasone propionate in normal subjects.
    Grove A; Allam C; McFarlane LC; McPhate G; Jackson CM; Lipworth BJ
    Br J Clin Pharmacol; 1994 Dec; 38(6):527-32. PubMed ID: 7888291
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of the systemic effects of inhaled glucocorticosteroids: the influence of blood sampling technique and frequency on plasma cortisol and leucocytes.
    Jennings BH; Andersson KE; Johansson SA
    Eur J Clin Pharmacol; 1990; 39(2):127-31. PubMed ID: 2253661
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An assessment of the systemic effects of single and repeated doses of inhaled fluticasone propionate and inhaled budesonide in healthy volunteers.
    Lönnebo A; Grahnén A; Jansson B; Brundin RM; Ling-Andersson A; Eckernäs SA
    Eur J Clin Pharmacol; 1996; 49(6):459-63. PubMed ID: 8706770
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adrenocortical activity with repeated twice daily dosing of fluticasone propionate and budesonide given via a large volume spacer to asthmatic school children.
    Lipworth BJ; Clark DJ; McFarlane LC
    Thorax; 1997 Aug; 52(8):686-9. PubMed ID: 9337826
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Growth and pituitary-adrenal function in children with severe asthma treated with inhaled budesonide.
    Volovitz B; Amir J; Malik H; Kauschansky A; Varsano I
    N Engl J Med; 1993 Dec; 329(23):1703-8. PubMed ID: 8232459
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.